289
		Neoadjuvant chemotherapy reduces operative morbidity without effecting time to recurrence in advanced stage epithelial ovarian cancer
	
					
	
	Neoadjuvant chemotherapy reduces operative morbidity without effecting time to recurrence in advanced stage epithelial ovarian cancer
	Saturday, March 28, 2015: 9:55 AM
	Salon C-D (Hilton Chicago)
	
	
	
		
	
		
	
		
			
			 